Inhibition of downstream Ca2+-dependent signaling pathways using the Ca2+/calmodulin-dependent protein kinase II (CAMKII) inhibitor KN-62 also suppressed the enhancement of protein synthesis, consistent with previous reports identifying CAMKII signaling as a core mechanism underlying the development of cardiac hypertrophy and heart failure [51]. This evidence concerns the gene CAMK2G and heart failure.